How to treat post herpetic neuralgia?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: November 23, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Treatment of Post-Herpetic Neuralgia

Start with gabapentin as first-line therapy, initiating at 300 mg on day 1,600 mg on day 2, and 900 mg on day 3, then titrating to 1800-3600 mg/day in three divided doses, as recommended by the American College of Physicians and FDA labeling. 1, 2

First-Line Treatment Options

Gabapentin (Preferred Initial Agent)

  • Gabapentin is the recommended first-line oral pharmacological treatment with proven efficacy across 1800-3600 mg/day, though no additional benefit is demonstrated above 1800 mg/day 1, 2
  • The FDA-approved titration schedule is: 300 mg on day 1,600 mg/day (divided twice daily) on day 2, and 900 mg/day (divided three times daily) on day 3, with subsequent titration to 1800 mg/day (600 mg three times daily) 2
  • Maximum dosing interval should not exceed 12 hours between doses due to saturable absorption kinetics 3
  • An adequate trial requires 3-8 weeks for titration plus 2 weeks at maximum tolerated dose 3
  • In elderly patients or those with renal impairment, start with 100-200 mg/day and titrate more slowly 4, 3
  • Dose adjustment is mandatory in renal dysfunction: for CrCl <15 mL/min use 100-300 mg/day as single daily dose; for CrCl ≥60 mL/min use 900-3600 mg/day in three divided doses 3, 2

Topical Lidocaine 5% Patches

  • Topical lidocaine patches provide excellent efficacy (NNT = 2) with minimal systemic absorption, making them ideal for elderly patients or those with comorbidities 1
  • Can be worn for 12-24 hours on affected areas, particularly suitable for localized pain 1
  • This is the safest option due to negligible systemic effects 4

Tricyclic Antidepressants

  • Nortriptyline is preferred over amitriptyline with excellent efficacy (NNT = 2.64) and better tolerability 1, 5
  • Start at 10-25 mg at bedtime and increase every 3-7 days to a final dose of 25-100 mg at bedtime 1
  • Timing at bedtime minimizes daytime sedation effects 1

High-Concentration Capsaicin

  • The 8% capsaicin dermal patch provides pain relief for at least 12 weeks 1
  • Apply 4% lidocaine for 60 minutes before capsaicin application to mitigate erythema and pain side effects 1

Second-Line Treatment Options

Pregabalin

  • Consider pregabalin if gabapentin provides inadequate response, with NNT of 4.93 1
  • Effective dose typically ranges from 150-600 mg/day in two divided doses 4, 1
  • May be preferred over gabapentin for initial trial due to pharmacokinetics supporting easier and more rapid titration 4
  • Start with 25-50 mg/day in elderly patients, with lowest doses for moderate or greater renal impairment 4

Opioids (Use with Caution)

  • Opioids (oxycodone, extended-release morphine, methadone) show efficacy (NNT = 2.67) but should not be used as first-line agents due to risks of pronociception, cognitive impairment, respiratory depression, endocrine/immunological changes, and potential for misuse and addiction 1
  • Tramadol shows efficacy with NNT of 4.76 and may be considered as a safer opioid alternative 1

Combination Therapy

  • Combining morphine with gabapentin may be more effective when single agents provide inadequate relief, allowing lower doses of each medication while providing additive effects 1

Treatment Algorithm

  1. Start with gabapentin using FDA-approved titration schedule (300 mg day 1 → 600 mg day 2 → 900 mg day 3 → titrate to 1800-3600 mg/day) 2

    • Alternative: Start with topical lidocaine 5% patches if pain is localized or patient is elderly with multiple comorbidities 1
  2. If gabapentin is ineffective or not tolerated after adequate trial (3-8 weeks titration + 2 weeks at maximum dose), switch to nortriptyline 10-25 mg at bedtime, titrating to 25-100 mg 1, 3

  3. If monotherapy fails, add topical lidocaine patches or consider combination therapy (e.g., gabapentin + low-dose opioid) 1

  4. If still inadequate, trial pregabalin 150-600 mg/day in two divided doses 1

  5. For refractory cases, consider high-concentration capsaicin 8% patch or interventional treatments 1, 6

Special Considerations and Common Pitfalls

Elderly Patients

  • Always start with lower doses and titrate more slowly in elderly patients 4
  • Topical treatments are particularly valuable due to minimal systemic effects 4, 1
  • Gabapentinoids commonly cause somnolence, dizziness, and mental clouding in older patients, requiring careful monitoring 4

Medications to Avoid

  • Lamotrigine is not recommended for PHN due to lack of convincing evidence of efficacy and risk of lamotrigine-associated rash 1

Duration of Treatment

  • PHN may persist for months to years, and some patients require long-term treatment with no maximum duration specified 1
  • Periodic reassessment is recommended as PHN may improve over time 1

Side Effect Management

  • Approximately 80% of patients report somnolence with gabapentin, which is dose-dependent and can be minimized by starting low and titrating slowly 3
  • Other common side effects include dizziness, dry mouth, and constipation 3

Non-Pharmacological Adjuncts

  • Cognitive behavioral therapy, hypnosis, and physical/occupational therapy may provide additional benefit as part of multimodal therapy 1

References

Guideline

Treatment Options for Post-Herpetic Neuralgia

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Gabapentin Dosing for Postherpetic Neuralgia

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.